GlassScriptPhysician profile
Mckennan Thurston
NPI 1194088856
$7,254.83
in general payments reported to CMS, 2019-2025
66 companies · $1,062 in 2025
The $1,062 reported for 2025 was more than what 90% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $438 · 2021: $1,148 · 2022: $1,403 · 2023: $1,539 · 2024: $983 · 2025: $1,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,583.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,727.92 | 2021-2025 | Vraylar, Botox, Ubrelvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $658.18 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Lilly USA, LLC | $573.48 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $396.06 | 2019-2025 | |
| Glaxosmithkline, LLC. | $355.66 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Amgen INC. | $323.46 | 2019-2025 | Evenity, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $171.35 | 2019-2025 | Airsupra, Breztri |
| Astellas Pharma US INC | $167.09 | 2019-2025 | Veozah |
| Shield Therapeutics INC | $161.03 | 2023-2025 | Accrufer |
| Dynavax Technologies Corporation | $160.08 | 2019-2025 | Heplisav-B |
| Kyowa Kirin, INC. | $148.76 | 2023-2025 | Crysvita |
| Pacira Pharmaceuticals Incorporated | $138.98 | 2023 | Zilretta, Iovera |
| Merck Sharp & Dohme LLC | $136.84 | 2020-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Janssen Pharmaceuticals, INC | $134.10 | 2019-2024 | Spravato |
| Antares Pharma, INC. | $101.00 | 2020-2022 |
Show all 66 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mckennan Thurston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.